MIT

The Broad Institute's lawyers used statements from Jennifer Doudna to undermine UC's case that one could expect CRISPR/Cas9 to work in eukaryotic cells.

The platform, called Seq-Well, is similar to droplet-based approaches but reports increased efficiency.

Two Broad Institute teams, led by Eric Lander and Feng Zhang, respectively, have published new papers today in Science on new uses for lenti-CRISPR screens.

Researchers are making mutations in a cell's genome to mark it and later read out that information to create cell lineage maps and chemical interaction histories.

The method works by adding noise to database search results to confound algorithms that try to access private details about contributing individuals.

Discovered and characterized through a collaboration between Feng Zhang's lab and the NCBI, C2c2 opens up the RNA world to editing and other applications.